Randomized, Double-blind, Parallel-group, Placebo-controlled, 52-week, Phase IIb Study to AssessEfficacy and Safety of GLPG1690 on Top of Pirfenidone or Nintedanib in Patients with IdiopathicPulmonary Fibrosis (IPF)

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences